(-)-Cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) inhibits hepatitis B virus replication in primary human hepatocytes

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 520-523

  Condreay, Lynn D ^a,c   Condreay, J Patrick ^b   Jansen, Robert W ^a   Paff, Melanie T ^a   Averett, Devron R ^a  

^a Division of Experimental Therapy   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Burroughs Wellcome Co   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EMTRICITABINE;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG EFFICACY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0030032268     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.520     Document Type: Article

References (19)

1. Condreay, L. D. Unpublished data.
2. 1a. Condreay, L. D., and D. R. Averett. Hepatitis B and C viruses in hepatocellular carcinoma. In B. E. Huber and I MacGrath (ed.), Cancer therapy into the twenty-first century, vol. 2, in press. Futura Publishing Co., New York.
3. Condreay, L. D., R. W. Jansen, T. F. Powdrill, L. C. Johnson, D. W. Selleseth, M. T. Paff, S. M. Daluge, G. R. Painter, P. A. Furman, M. N. Ellis, and D. R. Averett. 1994. Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model. Antimicrob Agents Chemother. 38:616-619.
4. Furman, P. A., M. Davis, D. C. Liotta, M. Paff, L. W. Frick, D. J. Nelson, R. E. Dornsife, J. A. Wurster, L. J. Wilson, J. A. Fyfe, J. V. Tuttle, W. H. Miller, L. Condreay, D. R. Averett, R. F. Schinazi, and G. R. Painter. 1992. The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob. Agents Chemother 36:2686-2692.
5. Gripon, P., C. Diot, and C. Guguen-Guillouzo. 1993. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus effect of polyethylene glycol on adsorption and penetration. Virology 192:534-540.
6. Ho, H.-T., and M. J. M. Hitchcock. 1989. Cellular pharmacology of 2′, 3′-dideoxy-2′,3′-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus Antimicrob. Agents Chemother. 33:844-849
7. Jansen, R. W., L. C. Johnson, and D. R. Averett. 1993. High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific PCR assay Antimicrob. Agents Chemother. 37:441-477.
8. Johnson, L. Personal communication
9. Korba, B. E., and J. L. Gerin. 1992 Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication Antivir. Res 19:55-70.
10. Kreamer, B. L., J. L. Stacker, N. Sawada, G. L. Sattler, M. T. S. Hsia, and H. C. Pitot. 1986. Use of a low-speed, iso-density percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations. In Vitro Cell. Dev. Biol. 22:201-211.
11. Lanford, R. E., K. D. Carey, L. E. Estlack, G. C. Smith, and R. V. Hay. 1989. Analysis of plasma protein and lipoprotein synthesis in long-term primary cultures of baboon hepatocytes maintained in serum-free medium. In Vitro Cell Dev. Biol. 25:174-182
12. Ochiya, T., T. Tsurimoto, K. Ueda, K. Okubo, M. Shiozawa, and K. Matsubara. 1989. An in vitro system for infection with hepatitis B virus that uses primary human fetal hepatocytes. Proc. Natl. Acad Sci USA 86:1875-1879.
13. Paff, M. T., D. R. Averett, K. L. Prus, W. H. Miller, and D. J. Nelson. 1994. Intracellular metabolism of (-)- and (+)-cis-5-fluoro-1-[2-(hydroxymethy)-1,3-oxathiolan-5-yl]cytosine in HepG2 derivative 2 2,15 (subclone P5A) cells. Antimicrob. Agents Chemother. 38:1230-1238.
14. Sells, M. A., M.-L. Chen, and G. Acs. 1987 Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci USA 84:1005-1009.
15. Sells, M. A., A. Z. Zelent, M. Shvartsman, and G. Acs. 1988. Replicative intermediates of hepatitis B virus in HcpG2 cells that produce infectious virions. J. Virol. 62:2836-2844.
16. Starnes, M. C., and Y.-C. Cheng. 1987. Cellular metabolism of 2′,3′-dideoxycytidine, a compound active against human immunodeficiency virus in vitro. J. Biol. Chem 262:988-991.
17. Strom, S. C., R. L. Jirtle, R. S. Jones, D. L. Novicki, M. R. Rosenberg, A. Novotny, G. Irons, J. R. McLain, and G. Michalopoulos. 1982. Isolation, culture, and transplantation of human hepatocytes. JNCI 68:771-778.
18. Tsurimoto, T., A. Fujiyama, and K. Matsubara. 1987. Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA. Proc Natl. Acad. Sci. USA 84:444-448.
19. Ueda, K., T. Tsurimoto, T. Nagahata, O. Chisaka, and K. Matsubara. 1989. An in vitro system for screening anti-hepatitis B virus drugs. Virology 169:213-216.